PPIRE03748

Target Protein Information
Protein_Name Mu-type opioid receptor
Protein_Sequence MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
Organism_Source Homo sapiens
Functional_Classification G protein-coupled receptor
Cellular_Localization Plasma membrane
Gene_Names OPRM1
UniProt_ID P35372
Protein-Protein Interaction Networks
Peptide Basic Information
Peptide_Name D-Ala2-N-Me-Phe4-Gly-ol enkephalin(DAGO)
Peptide_Sequence YaGXo
Peptide_Length 5
Peptide_SMILES C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)NCC(=O)O
Chemical_Modification X4=N-methylphenylalanine; X5=C-terminal glycinol
Cyclization_Method None
Linear/Cyclic Linear
N-terminal_Modification None
C-terminal_Modification Free
Amino_Acid_Distribution
Peptide Physicochemical
Molecular_Weight 423.43
Aliphatic_Index 20.00000
Aromaticity 0.20000
Average_Rotatable_Bonds 2.20000
Charge_at_pH_7 -0.00287
Isoelectric_Point 6.09320
Number_of_Hydrogen_Bond_Acceptors 7
Number_of_Hydrogen_Bond_Donors 7
Topological_Polar_Surface_Area 199.95000
X_logP_energy -2.80010
Interaction Information
Affinity KD=0.19 nM
Affinity_Assay radioligand binding assay
PDB_ID None
Type Agonist
Structure
Reference Information
Document_Type Research Articles
Title Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145)through a partial interaction with opioid receptors.
Release_Year 1997
PMID 9369381
DOI 10.1016/S0014-2999(97)01213-2